InvestorsHub Logo
Followers 556
Posts 17440
Boards Moderated 42
Alias Born 10/21/2003

Re: Bobwins post# 10416

Monday, 03/26/2018 2:08:24 PM

Monday, March 26, 2018 2:08:24 PM

Post# of 10809
ATE.v/ATBPF -.02 to C$.47 well Antibe didn't hold so glad I at least sold 1/2 in the C$.60's. New report from Zack's give new price target of C$1.80 based on the successful phase II test.

http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2018/ATEV-Positive-Results-from-Phase-2b-Trial-of-ATB-346/default.aspx

Holding for regional licensing agreements but mainly for a Big Pharma to take ATB-346 thru phase III trials to commercialization. Such an agreement would include milestone payments to keep Antibe fundraising to a minimum and ~12% royalty payments on commercial sales.

But it ain't here yet so have to wait a few more months. Trying to nibble on a few shares at C$.46.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.